Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Aziz Karaoglu"'
Autor:
Huseyin Salih Semiz, Erdem Kisa, Eda Caliskan Yildirim, Elif Atag, Mehmet Emin Arayici, Talha Muezzinoglu, Aziz Karaoglu
Publikováno v:
Turkish Journal of Urology, Vol 48, Iss 4, Pp 287-293 (2022)
Externí odkaz:
https://doaj.org/article/9f12af2bddda42f2a541d801c1f67f3d
Autor:
Utku Oflazoglu, Umut Varol, Ahmet Alacacioglu, Tarik Salman, Necla Demir, Huseyin Salih Semiz, Aziz Karaoglu, Ilhan Oztop
Publikováno v:
Journal of Oncological Sciences, Vol 2, Iss 2, Pp 63-65 (2016)
Sunitinib and axitinib are oral tyrosine kinase inhibitors (TKI) that is commonly used in the treatment of metastatic renal cell carcinoma (RCC) as it has been shown to improve the progression-free survival of patients compared with sorafenib. Hypert
Externí odkaz:
https://doaj.org/article/e70a2971870d440a8d674c4258bbba53
Autor:
Hüseyin S. Semiz, Ülkü Küçük, Erdem Kısa, Merve Keskinkılıç, Dilara Ecem Süyün, Mehmet Emin Arayıcı, Elif Atağ, Aziz Karaoglu
Publikováno v:
The Prostate. 82:1564-1571
Background Prostate cancer is a cancer with poor host immune response and could be defined as a non-T-cell inflamed tumor. Therefore, immunotherapy treatments could not be included in the treatment of prostate cancer until recently. Inadequate antitu
Autor:
Tayfun Bisgin, Selman Sokmen, Vildan Avkan-Oguz, Funda Obuz, Aziz Karaoglu, Hulya Ellidokuz, Ozgul Sagol
In this study, we aimed to investigate the prognostic impact of splenectomy on post-operative complications and the long-term oncologic results of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for treating peritoneal metastasis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::759dbde84654e9d5adca60e22ff9ddb0
https://avesis.deu.edu.tr/publication/details/7fa0f6cb-a9f9-4499-864e-7b142fdcd3ec/oai
https://avesis.deu.edu.tr/publication/details/7fa0f6cb-a9f9-4499-864e-7b142fdcd3ec/oai
Autor:
Elcin Bora, Ahmet Okay Caglayan, Altug Koc, Tufan Cankaya, Hande Ozkalayci, Mehmet Kocabey, Demet Kemer, Suleyman Aksoy, Zumre Arican Alicikus, Isil Basara Akin, Merih Guray Durak, Duygu Gurel, Tugba Yavuzsen, Ali Sevinc, Isil Somali, Ilknur Gorken, Pinar Balci, Aziz Karaoglu, Serdar Saydam, Ayfer Ulgenalp
Publikováno v:
Cancer Genetics. :118-133
Breast cancer, a worldwide leading cause of cancer in women, may occur in familial cases. Germline mutations in BRCA1/2 genes are responsible for 15% of the familial cases. With the power of next generation sequencing (NGS) analysis, it is possible t
Autor:
Mustafa Kayabaşı, Ziya Ayhan, Banu Lebe, Ayşe Aydan Özkütük, Meltem Söylev Bajin, Arzu Nazlı, Eyüp Sabri Uçan, Aziz Karaoğlu, Ali Osman Saatci
Publikováno v:
Türk Oftalmoloji Dergisi, Vol 54, Iss 3, Pp 175-179 (2024)
A 78-year-old man with a history of lung cancer, chemotherapy, radiotherapy, and coronavirus disease 2019 infection experienced visual deterioration of two-weeks’ duration in his right eye. There was multifocal, yellowish-white retinitis foci, vasc
Externí odkaz:
https://doaj.org/article/fbc30ede40fb4858adf5bbaa508bc1b2
Autor:
Baran Akagündüz, Deniz Can Guven, Muhammet Ozer, Ilker Nihat Okten, Elif Atag, İlkay Tugba Unek, Ali Murat Tatli, Aziz Karaoglu
Publikováno v:
Journal of Geriatric Oncology. 14:101367
In most western countries, the median age of patients with CRC is around 70 years. Although the benefit of adjuvant chemotherapy has been established in stage III colon cancer, it remains controversial in patients with stage II disease. Colon cancer
Autor:
Mehmet Ali Nahit Sendur, Ahmet Taner Sümbül, Özlem Sönmez, Fatih Yildiz, Suayip Yalcin, Omer Dizdar, Ahmet Özet, Hakan Akbulut, Nazim Serdar Turhal, Gulnihal Tufan, Nuri Karadurmus, Serhat Ünal, Aziz Karaoglu, Ebru Çilbir
Publikováno v:
Journal of Oncological Sciences. 6:1-4
Autor:
Hüseyin Salih SEMİZ, Merve KESKİNKILIÇ, Halil İbrahim ELLEZ, Mehmet Emin ARAYICI, Aziz KARAOGLU
Publikováno v:
Volume: 6, Issue: 1 296-304
Journal of Basic and Clinical Health Sciences
Journal of Basic and Clinical Health Sciences
Objective: Prostate cancer is the the second common cancer in men in Turkey. We aimed to share our single center experience on the characteristics of patients with metastatic castration sensitive prostate cancer (mCSPC) and the factors affecting surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7715309a3f8268f32d4395e972fe2c29
https://dergipark.org.tr/tr/pub/jbachs/issue/68217/1057317
https://dergipark.org.tr/tr/pub/jbachs/issue/68217/1057317
Autor:
Irfan Cicin, Ozge Keskin, Osman Kostek, Aziz Karaoglu, Yuksel Urun, Büşra Kasım, Hacer Demir, Hakan Akbulut, Berna Oksuzoglu, Görkem Türkkan, Mutlu Dogan, Arzu Yaşar, Ozgur Tanriverdi, Fulden Yumuk, Ismail Erturk, Guliz Ozgun, Hasan Şenol Coşkun, Mustafa Gürbüz, Mehmet Ali Nahit Sendur, Sema Sezgin Goksu, Cagatay Arslan, Teoman Sakalar, Nuri Karadurmuş, Serkan Degirmencioglu, Ali Alkan, Burak Bilgin, Zeynep Gulsum Guc, Tugba Akin Telli, Elif Berna Köksoy
Publikováno v:
Journal of Men's Health, Vol 17, Iss 4, Pp 128-134 (2021)
Introduction: The efficacy and tolerability of Enzalutamide and Abiraterone Acetate have been reported in elderly patients with metastatic castration resistant prostate cancer (mCRPC). However, there is no randomized study directly comparing antitumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6865a8d3bf5688b09e6e731c3d40255
https://avesis.deu.edu.tr/publication/details/2142f911-2a12-45cf-a5a6-5285c1c985fb/oai
https://avesis.deu.edu.tr/publication/details/2142f911-2a12-45cf-a5a6-5285c1c985fb/oai